Skip to main content
Thank you for visiting nature.com. You are using a browser version
with limited support for CSS. To obtain the best experience, we
recommend you use a more up to date browser (or turn off
compatibility mode in Internet Explorer). In the meantime, to
ensure continued support, we are displaying the site without styles
and JavaScript.
Advertisement
[image]
[image]
•  View all journals
•  
Search
•  Log in
•  Content Explore content
•  About the journal
•  Publish with us
•  Subscribe
•  Sign up for alerts
•  RSS feed
1. nature 
2. nature reviews immunology 
3. review articles 
4. article
Show authors
•  Review Article
•  Published: 20 June 2014


Ectopic lymphoid-like
structures in infection, cancer
and autoimmunity
•  Costantino Pitzalis1,
•  Gareth W. Jones2,
•  Michele Bombardieri1 &
•  …
•  Simon A. Jones
2 
Nature Reviews Immunology volume 14, pages 447–462 (2014)Cite
this article
•  19k Accesses
•  628 Citations
•  6 Altmetric
•  Metrics details
Subjects
•  Lymphoid tissues
Key Points
•  Ectopic lymphoid-like structure neogenesis is a common
clinical occurrence and contributes to the pathology that is
associated with cancer, autoimmunity, infection and tissue
rejection. In this Review, we discuss the mechanisms that
drive the neogenesis of ectopic lymphoid-like structures and
their involvement in disease processes.
•  By drawing information from animal studies and clinical
observations, we consider why certain patients develop


ectopic lymphoid-like structures in inflamed tissues, whereas
others do not.
•  The current status of therapies that target ectopic lymphoid-
like structures is discussed.
•  We consider clinical approaches that may help to support the
diagnosis, treatment and clinical management of patients who
have ectopic lymphoid-like structures as part of their disease.
Abstract
Ectopic lymphoid-like structures often develop at sites of
inflammation where they influence the course of infection,
autoimmune disease, cancer and transplant rejection. These
lymphoid aggregates range from tight clusters of B cells and T cells
to highly organized structures that comprise functional germinal
centres. Although the mechanisms governing ectopic lymphoid
neogenesis in human pathology remain poorly defined, the presence
of ectopic lymphoid-like structures within inflamed tissues has been
linked to both protective and deleterious outcomes in patients. In
this Review, we discuss investigations in both experimental model
systems and patient cohorts to provide a perspective on the
formation and functions of ectopic lymphoid-like structures in
human pathology, with particular reference to the clinical
implications and the potential for therapeutic targeting.
 Access through your institution
Buy or subscribe
This is a preview of subscription content, access via your institution
Access options
 Access through your institution
Subscribe to this journal


Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Learn more
Buy this article
•  Purchase on SpringerLink
•  Instant access to full article PDF
Buy now
Prices may be subject to local taxes which are calculated during
checkout
Additional access options:
•  Log in
•  Learn about institutional subscriptions
•  Read our FAQs
•  Contact customer support
Figure 1: Mechanisms that control the induction and
maintenance of ectopic lymphoneogenesis.
[image]
Figure 2: Cytokines and chemokine regulate ELS formation and
function.
[image]
Similar content being viewed by others
[image]
Tertiary lymphoid structures in diseases: immune
mechanisms and therapeutic advances
Article Open access 28 August 2024


[image]
Tertiary lymphoid structures in anticancer immunity
Article 08 August 2024
[image]
Lymphatic vessels in the age of cancer
immunotherapy
Article 11 April 2024
References
1. Jones, S. A. Directing transition from innate to acquired
immunity: defining a role for IL-6. J. Immunol. 175, 3463–
3468 (2005).
Article  CAS  PubMed  Google Scholar 
2. Buckley, C. D. Why does chronic inflammation persist: An
unexpected role for fibroblasts. Immunol. Lett. 138, 12–14
(2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
3. McInnes, I. B. & Schett, G. Cytokines in the pathogenesis of
rheumatoid arthritis. Nature Rev. Immunol. 7, 429–442
(2007).
Article  CAS  Google Scholar 
4. Choy, E. H., Kavanaugh, A. F. & Jones, S. A. The problem of
choice: current biologic agents and future prospects in RA.
Nature Rev. Rheumatol. 9, 154–163 (2013).
Article  CAS  Google Scholar 
5. Jones, S. A., Scheller, J. & Rose-John, S. Therapeutic
strategies for the clinical blockade of IL-6/gp130 signaling. J.


Clin. Invest. 121, 3375–3383 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
6. Raza, K. The Michael Mason prize: early rheumatoid arthritis
—the window narrows. Rheumatology 49, 406–410 (2010).
Article  PubMed  Google Scholar 
7. Aloisi, F. & Pujol-Borrell, R. Lymphoid neogenesis in chronic
inflammatory diseases. Nature Rev. Immunol. 6, 205–217
(2006). This is an excellent commentary on the
development of lymphoid structures in disease.
Article  CAS  Google Scholar 
8. Neyt, K., Perros, F., GeurtsvanKessel, C. H., Hammad, H. &
Lambrecht, B. N. Tertiary lymphoid organs in infection and
autoimmunity. Trends Immunol. 33, 297–305 (2012).
Article  CAS  PubMed  Google Scholar 
9. Cañete, J. D. et al. Clinical significance of synovial lymphoid
neogenesis and its reversal after anti-tumour necrosis factor-α
therapy in rheumatoid arthritis. Ann. Rheum. Dis. 68, 751–
756 (2009). This study provides an example of how
distinct synovial histopathology may influence the
response to biological therapy. The presence of ELSs was
associated with an inferior response to anti-TNF therapy.
Article  CAS  PubMed  Google Scholar 
10. Coppola, D. et al. Unique ectopic lymph node-like structures
present in human primary colorectal carcinoma are identified
by immune gene array profiling. Am. J. Pathol. 179, 37–45
(2011).
Article  PubMed  PubMed Central  Google Scholar 
11. Drayton, D. L., Liao, S., Mounzer, R. H. & Ruddle, N. H.
Lymphoid organ development: from ontogeny to neogenesis.
Nature Immunol. 7, 344–353 (2006). This is an excellent


review about the mechanisms controlling lymphoid
neogenesis.
Article  CAS  Google Scholar 
12. De Togni, P. et al. Abnormal development of peripheral
lymphoid organs in mice deficient in lymphotoxin. Science
264, 703–707 (1994).
Article  CAS  PubMed  Google Scholar 
13. Kratz, A., Campos-Neto, A., Hanson, M. S. & Ruddle, N. H.
Chronic inflammation caused by lymphotoxin is lymphoid
neogenesis. J. Exp. Med. 183, 1461–1472 (1996).
Article  CAS  PubMed  Google Scholar 
14. Drayton, D. L., Ying, X., Lee, J., Lesslauer, W. & Ruddle, N. H.
Ectopic LTαβ directs lymphoid organ neogenesis with
concomitant expression of peripheral node addressin and a
HEV-restricted sulfotransferase. J. Exp. Med. 197, 1153–1163
(2003).
Article  CAS  PubMed  PubMed Central  Google Scholar 
15. Okabe, Y. & Medzhitov, R. Tissue-specific signals control
reversible program of localization and functional polarization
of macrophages. Cell 157, 832–844 (2014).
Article  CAS  PubMed  PubMed Central  Google Scholar 
16. Ruddle, N. H. Lymphatic vessels and tertiary lymphoid
organs. J. Clin. Invest. 124, 953–959 (2014).
Article  CAS  PubMed  PubMed Central  Google Scholar 
17. Meier, D. et al. Ectopic lymphoid-organ development occurs
through interleukin 7-mediated enhanced survival of
lymphoid-tissue-inducer cells. Immunity 26, 643–654 (2007).
This is an early report on the role of IL-7 and LTi cells in
lymphoid neogenesis.


Article  CAS  PubMed  Google Scholar 
18. Sawa, S. et al. Lineage relationship analysis of RORγt+ innate
lymphoid cells. Science 330, 665–669 (2010).
Article  CAS  PubMed  Google Scholar 
19. Schmutz, S. et al. Cutting edge: IL-7 regulates the peripheral
pool of adult RORγ+ lymphoid tissue inducer cells. J.
Immunol. 183, 2217–2221 (2009). The study describes the
role of RORγt in LTi cells and provides a potential link to
the involvement of T H 17-like cells in lymphoid
neogenesis.
Article  CAS  PubMed  Google Scholar 
20. Luther, S. A., Ansel, K. M. & Cyster, J. G. Overlapping roles of
CXCL13, interleukin 7 receptor-α, and CCR7 ligands in lymph
node development. J. Exp. Med. 197, 1191–1198 (2003).
Article  CAS  PubMed  PubMed Central  Google Scholar 
21. Yoshida, H. et al. Different cytokines induce surface
lymphotoxin-αβ on IL-7 receptor-α cells that differentially
engender lymph nodes and Peyer's patches. Immunity 17,
823–833 (2002). This study suggests that unique cellular
and molecular mechanisms contribute to lymphoid
neogenesis in distinct anatomical sites.
Article  CAS  PubMed  Google Scholar 
22. Sato, M. et al. Stromal activation and formation of lymphoid-
like stroma in chronic lung allograft dysfunction.
Transplantation 91, 1398–1405 (2011).
Article  CAS  PubMed  Google Scholar 
23. Rangel-Moreno, J., Moyron-Quiroz, J. E., Hartson, L., Kusser,
K. & Randall, T. D. Pulmonary expression of CXC chemokine
ligand 13, CC chemokine ligand 19, and CC chemokine ligand
21 is essential for local immunity to influenza. Proc. Natl
Acad. Sci. USA 104, 10577–10582 (2007). This study


demonstrates the importance of homeostatic chemokines
in the organization of lymphoid structures.
Article  CAS  PubMed  Google Scholar 
24. Braun, A., Takemura, S., Vallejo, A. N., Goronzy, J. J. &
Weyand, C. M. Lymphotoxin β-mediated stimulation of
synoviocytes in rheumatoid arthritis. Arthritis Rheum. 50,
2140–2150 (2004).
Article  CAS  PubMed  Google Scholar 
25. Takemura, S. et al. Lymphoid neogenesis in rheumatoid
synovitis. J. Immunol. 167, 1072–1080 (2001).
Article  CAS  PubMed  Google Scholar 
26. Timmer, T. C. et al. Inflammation and ectopic lymphoid
structures in rheumatoid arthritis synovial tissues dissected by
genomics technology: identification of the interleukin-7
signaling pathway in tissues with lymphoid neogenesis.
Arthritis Rheum. 56, 2492–2502 (2007). This is an
investigative study of ELS development in the context of
human disease.
Article  CAS  PubMed  Google Scholar 
27. Takatori, H. et al. Lymphoid tissue inducer-like cells are an
innate source of IL-17 and IL-22. J. Exp. Med. 206, 35–41
(2009).
Article  CAS  PubMed  PubMed Central  Google Scholar 
28. Deteix, C. et al. Intragraft Th17 infiltrate promotes lymphoid
neogenesis and hastens clinical chronic rejection. J. Immunol.
184, 5344–5351 (2010).
Article  CAS  PubMed  Google Scholar 
29. Peters, A. et al. Th17 cells induce ectopic lymphoid follicles
in central nervous system tissue inflammation. Immunity 35,
986–996 (2011).


Article  CAS  PubMed  PubMed Central  Google Scholar 
30. Rangel-Moreno, J. et al. The development of inducible
bronchus-associated lymphoid tissue depends on IL-17. Nature
Immunol. 12, 639–646 (2011). References 29 and 30
suggest a role of IL-17 and T H 17-like cells in ELS
development.
Article  CAS  Google Scholar 
31. Link, A. et al. Association of T-zone reticular networks and
conduits with ectopic lymphoid tissues in mice and humans.
Am. J. Pathol. 178, 1662–1675 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
32. Furtado, G. C. et al. TNFα-dependent development of
lymphoid tissue in the absence of RORγt lymphoid tissue
inducer cells. Mucosal Immunol. 7, 602–614 (2013). This
study supports a role for resident myeloid cells and
stromal cells in lymphoid neogenesis.
Article  CAS  PubMed  PubMed Central  Google Scholar 
33. Lochner, M. et al. Microbiota-induced tertiary lymphoid
tissues aggravate inflammatory disease in the absence of
RORγt and LTi cells. J. Exp. Med. 208, 125–134 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
34. Luther, S. A. et al. Differing activities of homeostatic
chemokines CCL19, CCL21, and CXCL12 in lymphocyte and
dendritic cell recruitment and lymphoid neogenesis. J.
Immunol. 169, 424–433 (2002).
Article  CAS  PubMed  Google Scholar 
35. Luther, S. A., Lopez, T., Bai, W., Hanahan, D. & Cyster, J. G.
BLC expression in pancreatic islets causes B cell recruitment
and lymphotoxin-dependent lymphoid neogenesis. Immunity
12, 471–481 (2000).


Article  CAS  PubMed  Google Scholar 
36. Chen, S. C. et al. Ectopic expression of the murine
chemokines CCL21a and CCL21b induces the formation of
lymph node-like structures in pancreas, but not skin, of
transgenic mice. J. Immunol. 168, 1001–1008 (2002).
Article  CAS  PubMed  Google Scholar 
37. Fan, L., Reilly, C. R., Luo, Y., Dorf, M. E. & Lo, D. Cutting
edge: ectopic expression of the chemokine TCA4/SLC is
sufficient to trigger lymphoid neogenesis. J. Immunol. 164,
3955–3959 (2000).
Article  CAS  PubMed  Google Scholar 
38. Slight, S. R. et al. CXCR5+ T helper cells mediate protective
immunity against tuberculosis. J. Clin. Invest. 123, 712–726
(2013).
CAS  PubMed  PubMed Central  Google Scholar 
39. Bombardieri, M. et al. Inducible tertiary lymphoid structures,
autoimmunity, and exocrine dysfunction in a novel model of
salivary gland inflammation in C57BL/6 mice. J. Immunol.
189, 3767–3776 (2012).
Article  CAS  PubMed  PubMed Central  Google Scholar 
40. Gu-Trantien, C. et al. CD4+ follicular helper T cell infiltration
predicts breast cancer survival. J. Clin. Invest. 123, 2873–
2892 (2013). This study uses imaging to correlate the
infiltration of T FH cells with clinical outcome in patients
with breast cancer.
Article  CAS  PubMed  PubMed Central  Google Scholar 
41. Breitfeld, D. et al. Follicular B helper T cells express CXC
chemokine receptor 5, localize to B cell follicles, and support
immunoglobulin production. J. Exp. Med. 192, 1545–1552
(2000).


Article  CAS  PubMed  PubMed Central  Google Scholar 
42. Schaerli, P. et al. CXC chemokine receptor 5 expression
defines follicular homing T cells with B cell helper function.
J. Exp. Med. 192, 1553–1562 (2000). This study describes
the original identification and functional
characterization of T FH cells.
Article  CAS  PubMed  PubMed Central  Google Scholar 
43. Nakayamada, S. et al. Early Th1 cell differentiation is marked
by a Tfh cell-like transition. Immunity 35, 919–931 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
44. Lu, K. T. et al. Functional and epigenetic studies reveal
multistep differentiation and plasticity of in vitro-generated
and in vivo-derived follicular T helper cells. Immunity 35,
622–632 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
45. Fahey, L. M. et al. Viral persistence redirects CD4 T cell
differentiation toward T follicular helper cells. J. Exp. Med.
208, 987–999 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
46. King, I. L. & Mohrs, M. IL-4–producing CD4+ T cells in
reactive lymph nodes during helminth infection are T
follicular helper cells. J. Exp. Med. 206, 1001–1007 (2009).
Article  CAS  PubMed  PubMed Central  Google Scholar 
47. Glatman Zaretsky, A. et al. T follicular helper cells
differentiate from Th2 cells in response to helminth antigens.
J. Exp. Med. 206, 991–999 (2009).
Article  CAS  PubMed  Google Scholar 
48. Bauquet, A. T. et al. The costimulatory molecule ICOS
regulates the expression of c-Maf and IL-21 in the


development of follicular T helper cells and TH17 cells.
Nature Immunol. 10, 167–175 (2009).
Article  CAS  Google Scholar 
49. Huber, M. et al. IRF4 is essential for IL-21-mediated
induction, amplification, and stabilization of the Th17
phenotype. Proc. Natl Acad. Sci. USA 105, 20846–20851
(2008).
Article  PubMed  Google Scholar 
50. Ma, C. S. et al. Functional STAT3 deficiency compromises the
generation of human T follicular helper cells. Blood 119,
3997–4008 (2012).
Article  CAS  PubMed  PubMed Central  Google Scholar 
51. Ma, C. S. et al. Deficiency of Th17 cells in hyper IgE
syndrome due to mutations in STAT3. J. Exp. Med. 205,
1551–1557 (2008).
Article  CAS  PubMed  PubMed Central  Google Scholar 
52. Mitsdoerffer, M. et al. Proinflammatory T helper type 17 cells
are effective B-cell helpers. Proc. Natl Acad. Sci. USA 107,
14292–14297 (2010).
Article  PubMed  Google Scholar 
53. Nurieva, R. I. et al. Generation of T follicular helper cells is
mediated by interleukin-21 but independent of T helper 1, 2,
or 17 cell lineages. Immunity 29, 138–149 (2008).
Article  CAS  PubMed  PubMed Central  Google Scholar 
54. Manzo, A. et al. Mature antigen-experienced T helper cells
synthesize and secrete the B cell chemoattractant CXCL13 in
the inflammatory environment of the rheumatoid joint.
Arthritis Rheum. 58, 3377–3387 (2008).
Article  CAS  PubMed  Google Scholar 


55. Tokoyoda, K. et al. Professional memory CD4+ T
lymphocytes preferentially reside and rest in the bone
marrow. Immunity 30, 721–730 (2009).
Article  CAS  PubMed  Google Scholar 
56. Odegard, J. M. et al. ICOS-dependent extrafollicular helper T
cells elicit IgG production via IL-21 in systemic
autoimmunity. J. Exp. Med. 205, 2873–2886 (2008).
Article  CAS  PubMed  PubMed Central  Google Scholar 
57. Marinkovic, T. et al. Interaction of mature CD3+CD4+ T cells
with dendritic cells triggers the development of tertiary
lymphoid structures in the thyroid. J. Clin. Invest. 116, 2622–
2632 (2006).
Article  CAS  PubMed  PubMed Central  Google Scholar 
58. Muniz, L. R., Pacer, M. E., Lira, S. A. & Furtado, G. C. A
critical role for dendritic cells in the formation of lymphatic
vessels within tertiary lymphoid structures. J. Immunol. 187,
828–834 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
59. GeurtsvanKessel, C. H. et al. Dendritic cells are crucial for
maintenance of tertiary lymphoid structures in the lung of
influenza virus-infected mice. J. Exp. Med. 206, 2339–2349
(2009).
Article  CAS  PubMed  PubMed Central  Google Scholar 
60. Halle, S. et al. Induced bronchus-associated lymphoid tissue
serves as a general priming site for T cells and is maintained
by dendritic cells. J. Exp. Med. 206, 2593–2601 (2009).
Article  CAS  PubMed  PubMed Central  Google Scholar 
61. Manser, T. Textbook germinal centers? J. Immunol. 172,
3369–3375 (2004).


Article  CAS  PubMed  Google Scholar 
62. Teng, G. & Papavasiliou, F. N. Immunoglobulin somatic
hypermutation. Annu. Rev. Genet. 41, 107–120 (2007).
Article  CAS  PubMed  Google Scholar 
63. Stavnezer, J., Guikema, J. E. & Schrader, C. E. Mechanism
and regulation of class switch recombination. Annu. Rev.
Immunol. 26, 261–292 (2008).
Article  CAS  PubMed  PubMed Central  Google Scholar 
64. Muramatsu, M. et al. Class switch recombination and
hypermutation require activation-induced cytidine deaminase
(AID), a potential RNA editing enzyme. Cell 102, 553–563
(2000).
Article  CAS  PubMed  Google Scholar 
65. Barreto, V., Reina-San-Martin, B., Ramiro, A. R., McBride, K.
M. & Nussenzweig, M. C. C-terminal deletion of AID
uncouples class switch recombination from somatic
hypermutation and gene conversion. Mol. Cell 12, 501–508
(2003).
Article  CAS  PubMed  Google Scholar 
66. Bombardieri, M. et al. Activation-induced cytidine deaminase
expression in follicular dendritic cell networks and
interfollicular large B cells supports functionality of ectopic
lymphoid neogenesis in autoimmune sialoadenitis and MALT
lymphoma in Sjogren's syndrome. J. Immunol. 179, 4929–
4938 (2007).
Article  CAS  PubMed  Google Scholar 
67. Humby, F. et al. Ectopic lymphoid structures support ongoing
production of class-switched autoantibodies in rheumatoid
synovium. PLoS Med. 6, e1 (2009). This study describes the
functional properties of ELSs in patients with rheumatoid
arthritis.


Article  PubMed  PubMed Central  Google Scholar 
68. Nacionales, D. C. et al. B cell proliferation, somatic
hypermutation, class switch recombination, and autoantibody
production in ectopic lymphoid tissue in murine lupus. J.
Immunol. 182, 4226–4236 (2009).
Article  CAS  PubMed  PubMed Central  Google Scholar 
69. Serafini, B. et al. Dysregulated Epstein–Barr virus infection in
the multiple sclerosis brain. J. Exp. Med. 204, 2899–2912
(2007).
Article  CAS  PubMed  PubMed Central  Google Scholar 
70. Takahashi, E. et al. Oral clarithromycin enhances airway
immunoglobulin A (IgA) immunity through induction of IgA
class switching recombination and B-cell-activating factor of
the tumor necrosis factor family molecule on mucosal
dendritic cells in mice infected with influenza A virus. J.
Virol. 86, 10924–10934 (2012).
Article  CAS  PubMed  PubMed Central  Google Scholar 
71. Cheng, J. et al. Ectopic B-cell clusters that infiltrate
transplanted human kidneys are clonal. Proc. Natl Acad. Sci.
USA 108, 5560–5565 (2011).
Article  PubMed  Google Scholar 
72. Scheel, T., Gursche, A., Zacher, J., Haupl, T. & Berek, C. V-
region gene analysis of locally defined synovial B and plasma
cells reveals selected B cell expansion and accumulation of
plasma cell clones in rheumatoid arthritis. Arthritis Rheum.
63, 63–72 (2011). This study provides a functional
evaluation of ELSs in patients with rheumatoid arthritis.
Article  CAS  PubMed  Google Scholar 
73. Stott, D. I., Hiepe, F., Hummel, M., Steinhauser, G. & Berek,
C. Antigen-driven clonal proliferation of B cells within the
target tissue of an autoimmune disease. The salivary glands of


patients with Sjogren's syndrome. J. Clin. Invest. 102, 938–
946 (1998).
Article  CAS  PubMed  PubMed Central  Google Scholar 
74. Grewal, J. S. et al. Salivary glands act as mucosal inductive
sites via the formation of ectopic germinal centers after site-
restricted MCMV infection. FASEB J. 25, 1680–1696 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
75. Khader, S. A. et al. In a murine tuberculosis model, the
absence of homeostatic chemokines delays granuloma
formation and protective immunity. J. Immunol. 183, 8004–
8014 (2009).
Article  CAS  PubMed  PubMed Central  Google Scholar 
76. Mazzucchelli, L. et al. BCA-1 is highly expressed in
Helicobacter pylori-induced mucosa-associated lymphoid tissue
and gastric lymphoma. J. Clin. Invest. 104, R49–R54 (1999).
Article  CAS  PubMed  PubMed Central  Google Scholar 
77. Mosnier, J. F. et al. The intraportal lymphoid nodule and its
environment in chronic active hepatitis C: an
immunohistochemical study. Hepatology 17, 366–371 (1993).
Article  CAS  PubMed  Google Scholar 
78. Ulrichs, T. et al. Human tuberculous granulomas induce
peripheral lymphoid follicle-like structures to orchestrate
local host defence in the lung. J. Pathol. 204, 217–228
(2004).
Article  PubMed  Google Scholar 
79. Moyron-Quiroz, J. E. et al. Role of inducible bronchus
associated lymphoid tissue (iBALT) in respiratory immunity.
Nature Med. 10, 927–934 (2004).
Article  CAS  PubMed  Google Scholar 


80. Xu, B. et al. Lymphocyte homing to bronchus-associated
lymphoid tissue (BALT) is mediated by L-selectin/PNAd,
α4β1 integrin/VCAM-1, and LFA-1 adhesion pathways. J.
Exp. Med. 197, 1255–1267 (2003).
Article  CAS  PubMed  PubMed Central  Google Scholar 
81. Moyron-Quiroz, J. E. et al. Persistence and responsiveness of
immunologic memory in the absence of secondary lymphoid
organs. Immunity 25, 643–654 (2006).
Article  CAS  PubMed  Google Scholar 
82. Manzo, A., Bombardieri, M., Humby, F. & Pitzalis, C.
Secondary and ectopic lymphoid tissue responses in
rheumatoid arthritis: from inflammation to autoimmunity and
tissue damage/remodeling. Immunol. Rev. 233, 267–285
(2010).
Article  CAS  PubMed  Google Scholar 
83. Bombardieri, M. & Pitzalis, C. Ectopic lymphoid neogenesis
and lymphoid chemokines in Sjogren's syndrome: at the
interplay between chronic inflammation, autoimmunity and
lymphomagenesis. Curr. Pharm. Biotechnol. 13, 1989–1996
(2012).
Article  CAS  PubMed  Google Scholar 
84. Berrih-Aknin, S., Ragheb, S., Le Panse, R. & Lisak, R. P.
Ectopic germinal centers, BAFF and anti-B-cell therapy in
myasthenia gravis. Autoimmun Rev. 12, 885–893 (2013).
Article  CAS  PubMed  Google Scholar 
85. Armengol, M. P. et al. Thyroid autoimmune disease:
demonstration of thyroid antigen-specific B cells and
recombination-activating gene expression in chemokine-
containing active intrathyroidal germinal centers. Am. J.
Pathol. 159, 861–873 (2001).
Article  CAS  PubMed  PubMed Central  Google Scholar 


86. Ekland, E. H., Forster, R., Lipp, M. & Cyster, J. G.
Requirements for follicular exclusion and competitive
elimination of autoantigen-binding B cells. J. Immunol. 172,
4700–4708 (2004).
Article  CAS  PubMed  Google Scholar 
87. Le Pottier, L. et al. Ectopic germinal centers are rare in
Sjogren's syndrome salivary glands and do not exclude
autoreactive B cells. J. Immunol. 182, 3540–3547 (2009).
Article  CAS  PubMed  Google Scholar 
88. Salomonsson, S. et al. Cellular basis of ectopic germinal
center formation and autoantibody production in the target
organ of patients with Sjogren's syndrome. Arthritis Rheum.
48, 3187–3201 (2003).
Article  CAS  PubMed  Google Scholar 
89. Shimaoka, Y. et al. Nurse-like cells from bone marrow and
synovium of patients with rheumatoid arthritis promote
survival and enhance function of human B cells. J. Clin. Invest.
102, 606–618 (1998).
Article  CAS  PubMed  PubMed Central  Google Scholar 
90. Pender, M. P. Infection of autoreactive B lymphocytes with
EBV, causing chronic autoimmune diseases. Trends Immunol.
24, 584–588 (2003).
Article  CAS  PubMed  Google Scholar 
91. Cavalcante, P. et al. Epstein–Barr virus persistence and
reactivation in myasthenia gravis thymus. Ann. Neurol. 67,
726–738 (2010).
PubMed  Google Scholar 
92. Croia, C. et al. Epstein–Barr virus persistence and infection of
autoreactive plasma cells in synovial lymphoid structures in
rheumatoid arthritis. Ann. Rheum. Dis. 72, 1559–1568 (2013).


This study provides an example of how viral infection
may influence the development and functional properties
of ELSs in autoimmune disease.
Article  CAS  PubMed  Google Scholar 
93. Croia, C. et al. Implication of Epstein–Barr virus infection in
disease-specific autoreactive B cell activation in ectopic
lymphoid structures of Sjogren's syndrome. Arthritis Rheum.
http://dx.doi.org/10.1002/art.38726 (2014).
94. Schonbeck, S., Padberg, F., Hohlfeld, R. & Wekerle, H.
Transplantation of thymic autoimmune microenvironment to
severe combined immunodeficiency mice. A new model of
myasthenia gravis. J. Clin. Invest. 90, 245–250 (1992).
Article  CAS  PubMed  PubMed Central  Google Scholar 
95. Thaunat, O. Pathophysiologic significance of B-cell clusters in
chronically rejected grafts. Transplantation 92, 121–126
(2011).
Article  PubMed  Google Scholar 
96. Thaunat, O. et al. Chronic rejection triggers the development
of an aggressive intragraft immune response through
recapitulation of lymphoid organogenesis. J. Immunol. 185,
717–728 (2010). This study provides an example of how
the development of severe inflammation following
chronic transplant rejection is accompanied by lymphoid
neogenesis.
Article  CAS  PubMed  Google Scholar 
97. Brown, K., Sacks, S. H. & Wong, W. Tertiary lymphoid organs
in renal allografts can be associated with donor-specific
tolerance rather than rejection. Eur. J. Immunol. 41, 89–96
(2011).
Article  CAS  PubMed  Google Scholar 
98. Le Texier, L. et al. Long-term allograft tolerance is


characterized by the accumulation of B cells exhibiting an
inhibited profile. Am. J. Transplant. 11, 429–438 (2011).
Article  CAS  PubMed  Google Scholar 
99. Dieu-Nosjean, M. C. et al. Long-term survival for patients
with non-small-cell lung cancer with intratumoral lymphoid
structures. J. Clin. Oncol. 26, 4410–4417 (2008).
Article  CAS  PubMed  Google Scholar 
100. de Chaisemartin, L. et al. Characterization of chemokines and
adhesion molecules associated with T cell presence in tertiary
lymphoid structures in human lung cancer. Cancer Res. 71,
6391–6399 (2011).
Article  CAS  PubMed  Google Scholar 
101. Bergomas, F. et al. Tertiary intratumor lymphoid tissue in
colo-rectal cancer. Cancers 4, 1–10 (2011).
Article  PubMed  PubMed Central  Google Scholar 
102. Nzula, S., Going, J. J. & Stott, D. I. Antigen-driven clonal
proliferation, somatic hypermutation, and selection of B
lymphocytes infiltrating human ductal breast carcinomas.
Cancer Res. 63, 3275–3280 (2003).
CAS  PubMed  Google Scholar 
103. Martinet, L. et al. Human solid tumors contain high
endothelial venules: association with T- and B-lymphocyte
infiltration and favorable prognosis in breast cancer. Cancer
Res. 71, 5678–5687 (2011).
Article  CAS  PubMed  Google Scholar 
104. Goc, J., Fridman, W. H., Sautes-Fridman, C. & Dieu-Nosjean,
M. C. Characteristics of tertiary lymphoid structures in
primary cancers. Oncoimmunology 2, e26836 (2013).
Article  PubMed  PubMed Central  Google Scholar 


105. Hamanishi, J. et al. Activated local immunity by CC
chemokine ligand 19-transduced embryonic endothelial
progenitor cells suppresses metastasis of murine ovarian
cancer. Stem Cells 28, 164–173 (2010).
CAS  PubMed  Google Scholar 
106. Liu, Y. et al. A genome-wide association study of psoriasis and
psoriatic arthritis identifies new disease loci. PLoS Genet. 4,
e1000041 (2008).
Article  CAS  PubMed  PubMed Central  Google Scholar 
107. Maiti, A. K. et al. Confirmation of an association between
rs6822844 at the Il2–Il21 region and multiple autoimmune
diseases: evidence of a general susceptibility locus. Arthritis
Rheum. 62, 323–329 (2010).
Article  CAS  PubMed  PubMed Central  Google Scholar 
108. van Heel, D. A. et al. A genome-wide association study for
celiac disease identifies risk variants in the region harboring
IL2 and IL21. Nature Genet. 39, 827–829 (2007).
Article  CAS  PubMed  Google Scholar 
109. Jones, J. L. et al. IL-21 drives secondary autoimmunity in
patients with multiple sclerosis, following therapeutic
lymphocyte depletion with alemtuzumab (Campath-1H). J.
Clin. Invest. 119, 2052–2061 (2009). This study provides an
example of how clinical intervention aids the
mechanistic understanding of ELS development in the
context of disease.
CAS  PubMed  PubMed Central  Google Scholar 
110. Mells, G. F. et al. Genome-wide association study identifies 12
new susceptibility loci for primary biliary cirrhosis. Nature
Genet. 43, 329–332 (2011).
Article  CAS  PubMed  Google Scholar 


111. Lessard, C. J. et al. Variants at multiple loci implicated in
both innate and adaptive immune responses are associated
with Sjogren's syndrome. Nature Genet. 45, 1284–1292
(2013).
Article  CAS  PubMed  Google Scholar 
112. Zhang, J. et al. Three SNPs in chromosome 11q23.3 are
independently associated with systemic lupus erythematosus
in Asians. Hum. Mol. Genet. 23, 524–533 (2014).
Article  CAS  PubMed  Google Scholar 
113. Lill, C. M. et al. MANBA, CXCR5, SOX8, RPS6KB1 and
ZBTB46 are genetic risk loci for multiple sclerosis. Brain 136,
1778–1782 (2013).
Article  PubMed  PubMed Central  Google Scholar 
114. Hislop, A. D., Taylor, G. S., Sauce, D. & Rickinson, A. B.
Cellular responses to viral infection in humans: lessons from
Epstein–Barr virus. Annu. Rev. Immunol. 25, 587–617 (2007).
Article  CAS  PubMed  Google Scholar 
115. Thorley-Lawson, D. A. Epstein–Barr virus: exploiting the
immune system. Nature Rev. Immunol. 1, 75–82 (2001).
Article  CAS  Google Scholar 
116. Pitzalis, C., Kelly, S. & Humby, F. New learnings on the
pathophysiology of RA from synovial biopsies. Curr. Opin.
Rheumatol. 25, 334–344 (2013).
Article  PubMed  Google Scholar 
117. van de Sande, M. G. et al. Presence of lymphocyte aggregates
in the synovium of patients with early arthritis in relationship
to diagnosis and outcome: is it a constant feature over time?
Ann. Rheum. Dis. 70, 700–703 (2011).
Article  PubMed  Google Scholar 


118. Ulrichs, T. et al. Differential organization of the local immune
response in patients with active cavitary tuberculosis or with
nonprogressive tuberculoma. J. Infect. Dis. 192, 89–97 (2005).
Article  PubMed  Google Scholar 
119. Shoenfeld, Y. & Isenberg, D. A. Mycobacteria and
autoimmunity. Immunol. Today 9, 178–182 (1988).
Article  CAS  PubMed  Google Scholar 
120. Sansonno, D. et al. Increased serum levels of the chemokine
CXCL13 and up-regulation of its gene expression are
distinctive features of HCV-related cryoglobulinemia and
correlate with active cutaneous vasculitis. Blood 112, 1620–
1627 (2008).
Article  CAS  PubMed  Google Scholar 
121. Sansonno, D. et al. Clonal analysis of intrahepatic B cells from
HCV-infected patients with and without mixed
cryoglobulinemia. J. Immunol. 160, 3594–3601 (1998).
CAS  PubMed  Google Scholar 
122. Ramos-Casals, M., De Vita, S. & Tzioufas, A. G. Hepatitis C
virus, Sjogren's syndrome and B-cell lymphoma: linking
infection, autoimmunity and cancer. Autoimmun Rev. 4, 8–15
(2005).
Article  PubMed  Google Scholar 
123. Deutsch, A. J. et al. MALT lymphoma and extranodal diffuse
large B-cell lymphoma are targeted by aberrant somatic
hypermutation. Blood 109, 3500–3504 (2007).
Article  CAS  PubMed  Google Scholar 
124. Hussell, T., Isaacson, P. G., Crabtree, J. E. & Spencer, J.
Helicobacter pylori-specific tumour-infiltrating T cells provide
contact dependent help for the growth of malignant B cells in
low-grade gastric lymphoma of mucosa-associated lymphoid


tissue. J. Pathol. 178, 122–127 (1996).
Article  CAS  PubMed  Google Scholar 
125. Wohrer, S., Troch, M. & Raderer, M. Therapy of gastric
mucosa-associated lymphoid tissue lymphoma. Expert Opin.
Pharmacother. 8, 1263–1273 (2007).
Article  PubMed  Google Scholar 
126. Bende, R. J. et al. Among B cell non-Hodgkin's lymphomas,
MALT lymphomas express a unique antibody repertoire with
frequent rheumatoid factor reactivity. J. Exp. Med. 201,
1229–1241 (2005).
Article  CAS  PubMed  PubMed Central  Google Scholar 
127. Klimiuk, P. A. et al. Circulating tumour necrosis factor-α and
soluble tumour necrosis factor receptors in patients with
different patterns of rheumatoid synovitis. Ann. Rheum. Dis.
62, 472–475 (2003).
Article  CAS  PubMed  PubMed Central  Google Scholar 
128. Kotake, S. et al. Activated human T cells directly induce
osteoclastogenesis from human monocytes: possible role of T
cells in bone destruction in rheumatoid arthritis patients.
Arthritis Rheum. 44, 1003–1012 (2001).
Article  CAS  PubMed  Google Scholar 
129. Dharmapatni, A. A. et al. TWEAK and Fn14 expression in the
pathogenesis of joint inflammation and bone erosion in
rheumatoid arthritis. Arthritis Res. Ther. 13, R51 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
130. Chang, A. et al. In situ B cell-mediated immune responses and
tubulointerstitial inflammation in human lupus nephritis. J.
Immunol. 186, 1849–1860 (2011).
Article  CAS  PubMed  Google Scholar 


131. Magliozzi, R. et al. A Gradient of neuronal loss and meningeal
inflammation in multiple sclerosis. Ann. Neurol. 68, 477–493
(2010).
Article  CAS  PubMed  Google Scholar 
132. Coronella-Wood, J. A. & Hersh, E. M. Naturally occurring B-
cell responses to breast cancer. Cancer Immunol. Immunother.
52, 715–738 (2003).
Article  PubMed  Google Scholar 
133. Denkert, C. et al. Tumor-associated lymphocytes as an
independent predictor of response to neoadjuvant
chemotherapy in breast cancer. J. Clin. Oncol. 28, 105–113
(2010).
Article  CAS  PubMed  Google Scholar 
134. Krell, J., Frampton, A. E. & Stebbing, J. The clinical
significance of tumor infiltrating lymphoctyes in breast
cancer: does subtype matter? BMC Cancer 12, 135 (2012).
Article  PubMed  PubMed Central  Google Scholar 
135. Liu, W., Peng, Y. & Tobin, D. J. A new 12-gene diagnostic
biomarker signature of melanoma revealed by integrated
microarray analysis. PeerJ 1, e49 (2013).
Article  CAS  PubMed  PubMed Central  Google Scholar 
136. Jonsson, G. et al. Gene expression profiling-based
identification of molecular subtypes in stage IV melanomas
with different clinical outcome. Clin. Cancer Res. 16, 3356–
3367 (2010).
Article  PubMed  Google Scholar 
137. DiLillo, D. J., Yanaba, K. & Tedder, T. F. B cells are required
for optimal CD4+ and CD8+ T cell tumor immunity:
therapeutic B cell depletion enhances B16 melanoma growth
in mice. J. Immunol. 184, 4006–4016 (2010).


Article  CAS  PubMed  PubMed Central  Google Scholar 
138. Shiao, S. L., Ganesan, A. P., Rugo, H. S. & Coussens, L. M.
Immune microenvironments in solid tumors: new targets for
therapy. Genes Dev. 25, 2559–2572 (2011).
Article  CAS  PubMed  PubMed Central  Google Scholar 
139. Chiavolini, D. et al. Bronchus-associated lymphoid tissue
(BALT) and survival in a vaccine mouse model of tularemia.
PLoS ONE 5, e11156 (2010).
Article  CAS  PubMed  PubMed Central  Google Scholar 
140. Thaunat, O. et al. B cell survival in intragraft tertiary
lymphoid organs after rituximab therapy. Transplantation 85,
1648–1653 (2008).
Article  CAS  PubMed  Google Scholar 
141. Badot, V. et al. Gene expression profiling in the synovium
identifies a predictive signature of absence of response to
adalimumab therapy in rheumatoid arthritis. Arthritis Res.
Ther. 11, R57 (2009).
Article  CAS  PubMed  PubMed Central  Google Scholar 
142. Fava, R. A. et al. A role for the lymphotoxin/LIGHT axis in
the pathogenesis of murine collagen-induced arthritis. J.
Immunol. 171, 115–126 (2003).
Article  CAS  PubMed  Google Scholar 
143. Gatumu, M. K. et al. Blockade of lymphotoxin-beta receptor
signaling reduces aspects of Sjogren's syndrome in salivary
glands of non-obese diabetic mice. Arthritis Res. Ther. 11, R24
(2009).
Article  CAS  PubMed  PubMed Central  Google Scholar 
144. Lee, Y. et al. Recruitment and activation of naive T cells in
the islets by lymphotoxin-β receptor-dependent tertiary


lymphoid structure. Immunity 25, 499–509 (2006).
Article  CAS  PubMed  Google Scholar 
145. Emu, B. et al. Safety, pharmacokinetics, and biologic activity
of pateclizumab, a novel monoclonal antibody targeting
lymphotoxin-α: results of a phase I randomized, placebo-
controlled trial. Arthritis Res. Ther. 14, R6 (2012).
Article  CAS  PubMed  PubMed Central  Google Scholar 
146. Zheng, B. et al. CXCL13 neutralization reduces the severity of
collagen-induced arthritis. Arthritis Rheum. 52, 620–626
(2005).
Article  CAS  PubMed  Google Scholar 
147. Kramer, J. M., Klimatcheva, E. & Rothstein, T. L. CXCL13 is
elevated in Sjogren's syndrome in mice and humans and is
implicated in disease pathogenesis. J. Leukoc. Biol. 94, 1079–
1089 (2013).
Article  CAS  PubMed  PubMed Central  Google Scholar 
148. Henry, R. A. & Kendall, P. L. CXCL13 blockade disrupts B
lymphocyte organization in tertiary lymphoid structures
without altering B cell receptor bias or preventing diabetes in
nonobese diabetic mice. J. Immunol. 185, 1460–1465 (2010).
Article  CAS  PubMed  Google Scholar 
149. Pelletier, D. & Hafler, D. A. Fingolimod for multiple sclerosis.
N. Engl. J. Med. 366, 339–347 (2012).
Article  CAS  PubMed  Google Scholar 
150. Mehling, M. et al. FTY720 therapy exerts differential effects
on T cell subsets in multiple sclerosis. Neurology 71, 1261–
1267 (2008).
Article  CAS  PubMed  Google Scholar 


151. Young, D. A. et al. Blockade of the interleukin-21/
interleukin-21 receptor pathway ameliorates disease in
animal models of rheumatoid arthritis. Arthritis Rheum. 56,
1152–1163 (2007).
Article  CAS  PubMed  Google Scholar 
152. Herber, D. et al. IL-21 has a pathogenic role in a lupus-prone
mouse model and its blockade with IL-21R.Fc reduces disease
progression. J. Immunol. 178, 3822–3830 (2007).
Article  CAS  PubMed  Google Scholar 
153. Frey, O. et al. Inducible costimulator (ICOS) blockade inhibits
accumulation of polyfunctional T helper 1/T helper 17 cells
and mitigates autoimmune arthritis. Ann. Rheum. Dis. 69,
1495–1501 (2010).
Article  CAS  PubMed  Google Scholar 
154. Hu, Y. L., Metz, D. P., Chung, J., Siu, G. & Zhang, M. B7RP-1
blockade ameliorates autoimmunity through regulation of
follicular helper T cells. J. Immunol. 182, 1421–1428 (2009).
Article  CAS  PubMed  Google Scholar 
155. Nanji, S. A. et al. Costimulation blockade of both inducible
costimulator and CD40 ligand induces dominant tolerance to
islet allografts and prevents spontaneous autoimmune
diabetes in the NOD mouse. Diabetes 55, 27–33 (2006).
Article  CAS  PubMed  Google Scholar 
156. Wengner, A. M. et al. CXCR5- and CCR7-dependent lymphoid
neogenesis in a murine model of chronic antigen-induced
arthritis. Arthritis Rheum. 56, 3271–3283 (2007).
Article  CAS  PubMed  Google Scholar 
157. Lee, B. H., Carcamo, W. C., Chiorini, J. A., Peck, A. B. &
Nguyen, C. Q. Gene therapy using IL-27 ameliorates Sjogren's
syndrome-like autoimmune exocrinopathy. Arthritis Res. Ther.


14, R172 (2012).
Article  CAS  PubMed  PubMed Central  Google Scholar 
158. Magliozzi, R. et al. Meningeal B-cell follicles in secondary
progressive multiple sclerosis associate with early onset of
disease and severe cortical pathology. Brain 130, 1089–1104
(2007).
Article  PubMed  Google Scholar 
159. Ludewig, B., Odermatt, B., Landmann, S., Hengartner, H. &
Zinkernagel, R. M. Dendritic cells induce autoimmune
diabetes and maintain disease via de novo formation of local
lymphoid tissue. J. Exp. Med. 188, 1493–1501 (1998).
Article  CAS  PubMed  PubMed Central  Google Scholar 
160. Astorri, E. et al. Evolution of ectopic lymphoid neogenesis
and in situ autoantibody production in autoimmune nonobese
diabetic mice: cellular and molecular characterization of
tertiary lymphoid structures in pancreatic islets. J. Immunol.
185, 3359–3368 (2010).
Article  CAS  PubMed  Google Scholar 
161. Sharifi, S., Murphy, M., Loda, M., Pinkus, G. S. & Khettry, U.
Nodular lymphoid lesion of the liver: an immune-mediated
disorder mimicking low-grade malignant lymphoma. Am. J.
Surg. Pathol. 23, 302–308 (1999).
Article  CAS  PubMed  Google Scholar 
162. Grant, A. J., Lalor, P. F., Hubscher, S. G., Briskin, M. &
Adams, D. H. MAdCAM-1 expressed in chronic inflammatory
liver disease supports mucosal lymphocyte adhesion to
hepatic endothelium (MAdCAM-1 in chronic inflammatory
liver disease). Hepatology 33, 1065–1072 (2001).
Article  CAS  PubMed  Google Scholar 
163. Grant, A. J. et al. Hepatic expression of secondary lymphoid


chemokine (CCL21) promotes the development of portal-
associated lymphoid tissue in chronic inflammatory liver
disease. Am. J. Pathol. 160, 1445–1455 (2002).
Article  CAS  PubMed  PubMed Central  Google Scholar 
164. Hill, M. E., Shiono, H., Newsom-Davis, J. & Willcox, N. The
myasthenia gravis thymus: a rare source of human
autoantibody-secreting plasma cells for testing potential
therapeutics. J. Neuroimmunol. 201–202, 50–56 (2008).
165. Nacionales, D. C. et al. Type I interferon production by
tertiary lymphoid tissue developing in response to 2,6,10,14-
tetramethyl-pentadecane (pristane). Am. J. Pathol. 168, 1227–
1240 (2006).
Article  CAS  PubMed  PubMed Central  Google Scholar 
166. Houtkamp, M. A., de Boer, O. J., van der Loos, C. M., van der
Wal, A. C. & Becker, A. E. Adventitial infiltrates associated
with advanced atherosclerotic plaques: structural
organization suggests generation of local humoral immune
responses. J. Pathol. 193, 263–269 (2001).
Article  CAS  PubMed  Google Scholar 
167. Grabner, R. et al. Lymphotoxin-β receptor signaling promotes
tertiary lymphoid organogenesis in the aorta adventitia of
aged ApoE−/− mice. J. Exp. Med. 206, 233–248 (2009).
Article  CAS  PubMed  PubMed Central  Google Scholar 
168. Carlsen, H. S., Baekkevold, E. S., Johansen, F. E., Haraldsen,
G. & Brandtzaeg, P. B cell attracting chemokine 1 (CXCL13)
and its receptor CXCR5 are expressed in normal and aberrant
gut associated lymphoid tissue. Gut 51, 364–371 (2002).
Article  CAS  PubMed  PubMed Central  Google Scholar 
169. Weninger, W. et al. Naive T cell recruitment to nonlymphoid
tissues: a role for endothelium-expressed CC chemokine
ligand 21 in autoimmune disease and lymphoid neogenesis. J.


Immunol. 170, 4638–4648 (2003).
Article  CAS  PubMed  Google Scholar 
170. Surawicz, C. M. & Belic, L. Rectal biopsy helps to distinguish
acute self-limited colitis from idiopathic inflammatory bowel
disease. Gastroenterology 86, 104–113 (1984).
Article  CAS  PubMed  Google Scholar 
171. Kaiserling, E. Newly-formed lymph nodes in the submucosa in
chronic inflammatory bowel disease. Lymphology 34, 22–29
(2001).
CAS  PubMed  Google Scholar 
172. McNamee, E. N. et al. Ectopic lymphoid tissue alters the
chemokine gradient, increases lymphocyte retention and
exacerbates murine ileitis. Gut 62, 53–62 (2013).
Article  CAS  PubMed  Google Scholar 
173. Demoor, T. et al. Role of lymphotoxin-α in cigarette smoke-
induced inflammation and lymphoid neogenesis. Eur. Respir.
J. 34, 405–416 (2009).
Article  CAS  PubMed  Google Scholar 
174. Hogg, J. C. et al. The nature of small-airway obstruction in
chronic obstructive pulmonary disease. N. Engl. J. Med. 350,
2645–2653 (2004).
Article  CAS  PubMed  Google Scholar 
175. Van Pottelberge, G. R. et al. Plasmacytoid dendritic cells in
pulmonary lymphoid follicles of patients with COPD. Eur.
Respir. J. 36, 781–791 (2010).
Article  CAS  PubMed  Google Scholar 
176. Nielsen, J. S. et al. CD20+ tumor-infiltrating lymphocytes
have an atypical CD27− memory phenotype and together


with CD8+ T cells promote favorable prognosis in ovarian
cancer. Clin. Cancer Res. 18, 3281–3292 (2012).
Article  CAS  PubMed  Google Scholar 
177. Curiel, T. J. et al. Specific recruitment of regulatory T cells in
ovarian carcinoma fosters immune privilege and predicts
reduced survival. Nature Med. 10, 942–949 (2004).
Article  CAS  PubMed  Google Scholar 
178. Eisenthal, A. et al. Expression of dendritic cells in ovarian
tumors correlates with clinical outcome in patients with
ovarian cancer. Hum. Pathol. 32, 803–807 (2001).
Article  CAS  PubMed  Google Scholar 
179. Yeung, M. M. et al. Characterisation of mucosal lymphoid
aggregates in ulcerative colitis: immune cell phenotype and
TcR-γδ expression. Gut 47, 215–227 (2000).
Article  CAS  PubMed  PubMed Central  Google Scholar 
180. Winter, S. et al. The chemokine receptor CXCR5 is pivotal for
ectopic mucosa-associated lymphoid tissue neogenesis in
chronic Helicobacter pylori-induced inflammation. J. Mol. Med.
88, 1169–1180 (2010).
Article  CAS  PubMed  PubMed Central  Google Scholar 
181. Shomer, N. H., Fox, J. G., Juedes, A. E. & Ruddle, N. H.
Helicobacter-induced chronic active lymphoid aggregates have
characteristics of tertiary lymphoid tissue. Infect. Immun. 71,
3572–3577 (2003).
Article  CAS  PubMed  PubMed Central  Google Scholar 
182. Ghosh, S., Steere, A. C., Stollar, B. D. & Huber, B. T. In situ
diversification of the antibody repertoire in chronic Lyme
arthritis synovium. J. Immunol. 174, 2860–2869 (2005).
Article  CAS  PubMed  Google Scholar 


183. Rangel-Moreno, J. et al. Omental milky spots develop in the
absence of lymphoid tissue-inducer cells and support B and T
cell responses to peritoneal antigens. Immunity 30, 731–743
(2009).
Article  CAS  PubMed  PubMed Central  Google Scholar 
184. Beelen, R. H., Oosterling, S. J., van Egmond, M., van den
Born, J. & Zareie, M. Omental milky spots in peritoneal
pathophysiology (spots before your eyes). Perit. Dial. Int. 25,
30–32 (2005).
PubMed  Google Scholar 
185. Di Paolo, N. et al. Omental milky spots and peritoneal dialysis
— review and personal experience. Perit. Dial. Int. 25, 48–57
(2005).
PubMed  Google Scholar 
186. Hiramatsu, K. et al. Inhalation of diesel exhaust for three
months affects major cytokine expression and induces
bronchus-associated lymphoid tissue formation in murine
lungs. Exp. Lung Res. 29, 607–622 (2003).
Article  CAS  PubMed  Google Scholar 
187. Mahendra, G. et al. Necrotic and inflammatory changes in
metal-on-metal resurfacing hip arthroplasties. Acta Orthop.
80, 653–659 (2009).
Article  PubMed  PubMed Central  Google Scholar 
188. Perros, F. et al. Pulmonary lymphoid neogenesis in idiopathic
pulmonary arterial hypertension. Am. J. Respir. Crit. Care
Med. 185, 311–321 (2012).
Article  PubMed  Google Scholar 
Download references


Acknowledgements
G.W.J. is funded by Arthritis Research UK as a non-clinical Career
Development Fellow.
Author information
Authors and Affiliations
1. Centre for Experimental Medicine and Rheumatology,
William Harvey Research Institute, Barts and The London,
School of Medicine and Dentistry, Queen Mary University of
London, Charterhouse Square, London, EC1M 6BQ, UK
Costantino Pitzalis & Michele Bombardieri
2. Cardiff Institute for Infection and Immunity, The School of
Medicine, Cardiff University, The Tenovus Building, Heath
Campus, Cardiff, CF14 4XN, Wales, UK
Gareth W. Jones & Simon A. Jones
Authors
1. Costantino Pitzalis
View author publications
Search author on:PubMed Google Scholar
2. Gareth W. Jones
View author publications
Search author on:PubMed Google Scholar
3. Michele Bombardieri
View author publications
Search author on:PubMed Google Scholar
4. Simon A. Jones


View author publications
Search author on:PubMed Google Scholar
Corresponding author
Correspondence to Simon A. Jones.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
FURTHER INFORMATION
ClinicalTrials.gov
PowerPoint slides
PowerPoint slide for Fig. 1
PowerPoint slide for Fig. 2
PowerPoint slide for Table 1
PowerPoint slide for Table 2
Glossary


Secondary lymphoid organs
(SLOs). In contrast to primary (central) lymphoid organs,
where lymphocytes are generated from immature
progenitor cells, SLOs — that is, the spleen, Peyer's patches
and lymph nodes — maintain mature naive lymphocytes
and are sites of lymphocyte activation by antigen.
Lymphoid neogenesis
The de novo development and cellular organization of
lymphoid tissue into distinct anatomical and functional
compartments.
Ectopic lymphoid-like structures
(ELSs). Highly organized lymphoid aggregates that form in
tissue sites that are not typically associated with lymphoid
neogenesis.
Encapsulated SLOs
Organized secondary lymphoid organs (SLOs) that are
encased in a connective tissue capsule that contains blood
vessels.
Lymphoid tissue inducer cells
(LTi cells). These cells are present in developing lymph
nodes, Peyer's patches and nasopharynx-associated
lymphoid tissue (NALT) and they are required for the
development of these lymphoid organs. The inductive
capacity of LTi cells for the generation of Peyer's patches
and NALT has been shown by adoptive transfer and it is
generally assumed that they have a similar function in the
formation of lymph nodes.
T follicular helper cells
(TFH cells). Antigen-experienced CD4+ T cells that are
present in B cell-rich regions of structurally organized
lymphoid aggregates or organs.


Lymphoid tissue organizer cells
These cells are of mesenchymal origin that are activated by
lymphoid cells through lymphotoxin-β receptor signalling
to express adhesion molecules and chemokines that
regulate lymphoid tissue development.
High endothelial venules
(HEVs). These are specialized venules that occur in
secondary lymphoid organs, except the spleen. HEVs allow
the continuous transmigration of lymphocytes as a
consequence of the constitutive expression of adhesion
molecules and chemokines at their luminal surface.
Innate lymphoid cell
(ILC). A type of innate immune cell that is lymphoid in
morphology and developmental origin but that lacks
properties of adaptive B cells and T cells, such as
recombined antigen-specific receptors. These cells regulate
immunity, tissue homeostasis and inflammation in response
to cytokine stimulation.
Germinal centre
Located in peripheral lymphoid tissues (for example, the
spleen or lymph nodes), these are sites in which B cells
proliferate and clones that produce antigen-specific
antibodies of higher affinity are selected.
Angiogenesis
The development of new blood vessels from existing blood
vessels. It is frequently associated with tumour
development and inflammation.
Activation-induced cytidine deaminase
(AID). An enzyme that is required for two crucial events in
the germinal centre — somatic hypermutation and class-
switch recombination.


Granuloma
A chronic inflammatory tissue response that occurs at the
site of implantation of certain foreign bodies and, in
particular, at sites of long-term microbial persistence.
Granulomas are typically well-organized structures that are
composed of T cells and macrophages, some of which fuse
to form giant cells.
Severe combined immunodeficiency mice
(SCID mice). A strain of mice that possesses a genetic defect
in DNA recombination that leads to severe
immunodeficiency. SCID mice lack B cells and T cells, and
they are incompetent at rejecting tissue grafts from
allogeneic and xenogeneic sources.
Cryoglobulinaemia
An autoimmune, extra-hepatic manifestation that is
associated with certain viral infections and chronic
inflammatory conditions, whereby antigen–antibody
complexes are deposited in capillaries and arterioles (and
occasionally small arteries) causing vasculitis, renal disease,
arthralgias or arthritis.
Non-obese diabetic mice
(NOD mice). These mice spontaneously develop diabetes as
a result of autoreactive T cell-mediated destruction of
pancreatic β-islet cells.
Rights and permissions
Reprints and permissions
About this article


[image]
Cite this article
Pitzalis, C., Jones, G., Bombardieri, M. et al. Ectopic lymphoid-like
structures in infection, cancer and autoimmunity. Nat Rev Immunol
14, 447–462 (2014). https://doi.org/10.1038/nri3700
Download citation
•  Published: 20 June 2014
•  Issue date: July 2014
•  DOI: https://doi.org/10.1038/nri3700
Share this article
Anyone you share the following link with will be able to read this
content:
Get shareable link
Sorry, a shareable link is not currently available for this article.
Copy shareable link to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative
This article is cited by
•  The roles of tertiary lymphoid structures in
chronic diseases
○  Yuki Sato
○  Karina Silina
○  Motoko Yanagita


Nature Reviews Nephrology (2023)
•  Peripheral helper-T-cell-derived CXCL13 is a
crucial pathogenic factor in idiopathic
multicentric Castleman disease
○  Takuya Harada
○  Yoshikane Kikushige
○  Kazuyuki Yoshizaki
Nature Communications (2023)
•  B cells and tertiary lymphoid structures are
associated with survival in papillary thyroid
cancer
○  Y.-Y. Li
○  S.-J. Li
○  Z.-X. Lian
Journal of Endocrinological Investigation (2023)
•  The immunopathology of B lymphocytes during
stroke-induced injury and repair
○  Mary K. Malone
○  Thomas A. Ujas
○  Ann M. Stowe
Seminars in Immunopathology (2023)
•  Tertiary Lymphoid Structures Are Associated
with a Favorable Prognosis in High-Grade Serous
Ovarian Cancer Patients
○  Ke Zhang
○  Xiao Xie
○  Sui-Qun Guo


Reproductive Sciences (2023)
 Access through your institution
Buy or subscribe
Advertisement
[image]
Explore content
•  Research articles
•  Reviews & Analysis
•  News & Comment
•  Videos
•  Current issue
•  Collections
•  Follow us on Facebook
•  Follow us on Twitter
•  Subscribe
•  Sign up for alerts
•  RSS feed
About the journal
•  Aims & Scope
•  Journal Information
•  Editorial policies
•  About the Editors
•  Reviews Cross-Journal Editorial Team
•  Journal Credits
•  Editorial input and checks
•  Editorial Values Statement
•  Journal Metrics
•  Publishing model


•  Calendars
•  Conferences
•  Posters
•  Web Feeds
•  Contact
Publish with us
•  For Authors
•  For Referees
•  Submit manuscript
Search
Search articles by subject, keyword or author
Show results from All journals This journal
Search
Advanced search
Quick links
•  Explore articles by subject
•  Find a job
•  Guide to authors
•  Editorial policies
Nature Reviews Immunology (Nat Rev Immunol)
ISSN 1474-1741 (online)
ISSN 1474-1733 (print)
nature.com sitemap


About Nature Portfolio
•  About us
•  Press releases
•  Press office
•  Contact us
Discover content
•  Journals A-Z
•  Articles by subject
•  protocols.io
•  Nature Index
Publishing policies
•  Nature portfolio policies
•  Open access
Author & Researcher services
•  Reprints & permissions
•  Research data
•  Language editing
•  Scientific editing
•  Nature Masterclasses
•  Research Solutions
Libraries & institutions
•  Librarian service & tools
•  Librarian portal
•  Open research
•  Recommend to library
Advertising & partnerships
•  Advertising
•  Partnerships & Services


•  Media kits
•  Branded content
Professional development
•  Nature Awards
•  Nature Careers
•  Nature Conferences
Regional websites
•  Nature Africa
•  Nature China
•  Nature India
•  Nature Japan
•  Nature Middle East
•  Privacy Policy
•  Use of cookies
•  Your privacy choices/Manage cookies
•  Legal notice
•  Accessibility statement
•  Terms & Conditions
•  Your US state privacy rights
[image]
© 2025 Springer Nature Limited


 Close
[image]
Sign up for the Nature Briefing newsletter — what matters in
science, free to your inbox daily.
Email address


Sign up
I agree my information will be processed in accordance with the
Nature and Springer Nature Limited Privacy Policy.
 Close
Get the most important science stories of the day, free in your
inbox. Sign up for Nature Briefing
[image]


